Epilepsy Headlines

Cortical Excitability Tied to Duration and Degree of Seizure Control

Cortical Excitability Tied to Duration and Degree of Seizure Control

This study identified a feature of the epileptic brain that evolves slowly and differs fundamentally in well-controlled and poorly controlled epilepsy.

Autoimmune Etiology Suggested for Subset of Epilepsy Diagnoses

Autoimmune Etiology Suggested for Subset of Epilepsy Diagnoses

A subset of epilepsy cases of unknown etiology may be secondary to the production of autoantibodies.

Epilepsy Treatment Often Delayed in Older Adults

Epilepsy Treatment Often Delayed in Older Adults

Despite recommendations, many patients in the cohort were prescribed older antiepileptic drugs.

Epilepsy Education Group Helps Patients Cope With Isolation, Anger

Epilepsy Education Group Helps Patients Cope With Isolation, Anger

Patients who participated in a group course with other people with epilepsy felt less isolated and more confident.

Maternal Antiepileptic Use and Risk for Major Congenital Malformations in Offspring

Maternal Antiepileptic Use and Risk for Major Congenital Malformations in Offspring

A diagnosis of maternal epilepsy alone was not associated with an increase in congenital malformations in offspring.

Quality Improvement Measures Improve Health Care Utilization in Epilepsy

Quality Improvement Measures Improve Health Care Utilization in Epilepsy

Quality improvement measures help to reduce emergency department visits, inpatient hospitalizations, and health care claims.

Epileptic Seizures in Multiple Sclerosis May Suggest Shared Pathology

Epileptic Seizures in Multiple Sclerosis May Suggest Shared Pathology

Patients with both MS and epileptic seizures had a younger age at onset of MS compared with those without seizures.

Should EEG Periodic Discharges be Managed Similarly to Seizures?

Should EEG Periodic Discharges be Managed Similarly to Seizures?

Brain oxygenation may be compromised during periodic discharges, ultimately warranting treatment.

Seizure Reduction Likely With Surgery in Nonlesional Neocortical Epilepsy

Seizure Reduction Likely With Surgery in Nonlesional Neocortical Epilepsy

Nearly 60% of patients had achieved seizure freedom at last follow-up, 10 to 21 years after surgery.

EEG Patterns in Critically Ill Point to Greater Risk of Seizures

EEG Patterns in Critically Ill Point to Greater Risk of Seizures

Careful monitoring of EEG patterns is a useful way to stratify seizure risk in critically ill patients.

First-Line Treatment With Carbamazepine in Neonatal Epilepsy

First-Line Treatment With Carbamazepine in Neonatal Epilepsy

The results confirm the effectiveness and safety of low-dose CBZ as a first-line agent for the treatment of neonatal seizures.

Vigabatrin Plus Hormonal Therapy Superior in Infantile Spasms

Vigabatrin Plus Hormonal Therapy Superior in Infantile Spasms

Greater spasm cessation was achieved in the combination group vs those who received hormonal therapy alone.

VIDEO: Identifying Risk Factors for Post-Stroke Epilepsy

VIDEO: Identifying Risk Factors for Post-Stroke Epilepsy

Beate Diehl, MD, PhD, FRCP, discusses her research on post-stroke epilepsy.

VIDEO: Gap in Provider Knowledge Delays Diagnosis, Treatment of Infantile Spasms

VIDEO: Gap in Provider Knowledge Delays Diagnosis, Treatment of Infantile Spasms

Shaun Hussain, MD, MS, discusses a gap in health care provider knowledge that may contribute to the delay in the diagnosis and treatment of infantile spasms.

VIDEO: Elizabeth Thiele, MD, PhD Discusses Latest Cannabidiol Research

VIDEO: Elizabeth Thiele, MD, PhD Discusses Latest Cannabidiol Research

Elizabeth Thiele, MD, PhD discusses results from her research on cannabidiol in Lennox-Gastaut syndrome.

Significant Drug-Drug Interactions With Cannabidiol and Antiepileptics

Significant Drug-Drug Interactions With Cannabidiol and Antiepileptics

Clobazam had been previously identified as an AED with a significant interaction with CBD.

VIDEO — Industry Update: Justin Gover, CEO, GW Pharmaceuticals on Epidiolex Status

VIDEO — Industry Update: Justin Gover, CEO, GW Pharmaceuticals on Epidiolex Status

Justin Gover, CEO of GW Pharmaceuticals, the parent company of Greenwich Biosciences, discusses the status of the company's cannabidiol product Epidiolex on the heels of positive results from several placebo-controlled trials in epileptic syndromes.

Social Support a Significant Factor in Development of Anxiety, Depression in Epilepsy

Social Support a Significant Factor in Development of Anxiety, Depression in Epilepsy

Number of AEDs and seizure frequency also influenced depression in people with epilepsy.

Accurate Surgical Localization Using Combined Imaging Approach in Epilepsy

Accurate Surgical Localization Using Combined Imaging Approach in Epilepsy

Concordant EEG/fMRI and ESI predicted outcomes with 100% sensitivity and specificity.

Factors Predictive of Everolimus Efficacy in Tuberous Sclerosis Complex

Factors Predictive of Everolimus Efficacy in Tuberous Sclerosis Complex

Adjunctive everolimus treatment has been found to significantly reduce frequency of treatment-resistant seizures in TSC.

Sign Up for Free e-newsletters